Cite
HARVARD Citation
Palma, D. et al. (n.d.). 157: A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiotherapy (SABR) Plus Surgery in Operable Patients with Early Non-Small Cell Lung Cancer (Missile-NSCLC): Interim Safety Results. Radiotherapy and oncology. pp. S58-. [Online].